Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2014
12/25/2014US20140378557 Formulation Solution Adapted to Prolong Plasma Times of Drugs in Mammals Including Humans
12/25/2014US20140378551 Composition for the Prophylactic Treatment of Neuropathic Pain
12/25/2014US20140378549 Implantation compositions for use in tissue augmentation
12/25/2014US20140378548 Inhibitor of trpm-4 ion channel for treating or preventing neurodegeneration
12/25/2014US20140378547 Antioxidant compositions for treatment of inflammation or oxidative damage
12/25/2014US20140378546 Method of treating postural reflex abnormality caused by parkinson's disease
12/25/2014US20140378545 Pregabalin gr tablets
12/25/2014US20140378543 Methods of producing and using nutritional and pharmaceutical compositions that include one or more active substances
12/25/2014US20140378542 Cocrystals of dimethyl fumarate
12/25/2014US20140378541 Synthetic Epigallocatechin Gallate (EGCG) Analogs
12/25/2014US20140378539 Cannabinoids for use in the treatment of neuropathic pain
12/25/2014US20140378534 Treatment and diagnosis of colon cancer
12/25/2014US20140378532 Glycogen-based cationic polymers
12/25/2014US20140378531 Inhibition of pattern recognition receptors in pancreatic cancer treatment using tlr inhibitors
12/25/2014US20140378530 Retinaldehyde mimetics and inhibitors of retinaldehyde dehydrogenase i in the treatment of disorders
12/25/2014US20140378529 Collateral gene inactivation biomarkers and targets for cancer therapy
12/25/2014US20140378528 Biomarkers of mir-34 activity
12/25/2014US20140378525 Materials and methods for treating pten mutated or deficient cancer
12/25/2014US20140378524 Methods and compositions comprising akt inhibitors and/or phospholipase d inhibitors
12/25/2014US20140378522 Unifying mechanism and methods to prevent cancer and neurodegenerative diseases
12/25/2014US20140378521 Use of nk-1 receptor antagonists in pruritus
12/25/2014US20140378519 Optical correction
12/25/2014US20140378518 Lyophilized formulations of bendamustine hydrochloride
12/25/2014US20140378517 Formulations of enzalutamide
12/25/2014US20140378516 Compositions, methods of use, and methods of treatment
12/25/2014US20140378512 Composition for improving cognition and memory
12/25/2014US20140378508 Use of high dose pridopidine for treating huntington's disease
12/25/2014US20140378505 Sns-595 and methods of using the same
12/25/2014US20140378503 Anti-cancer compounds
12/25/2014US20140378502 Par1 Inhibitors for Use in the Treatment or Prevention of Paramyxoviridae Infections
12/25/2014US20140378501 Scopolamine for the treatment of depression and anxiety
12/25/2014US20140378499 Methods and compositions for treating or preventing symptoms of hormonal variations
12/25/2014US20140378498 Tamper Resistant Composition Comprising Hydrocodone And Acetaminophen For Rapid Onset And Extended Duration Of Analgesia
12/25/2014US20140378497 Sublingual and buccal film compositions
12/25/2014US20140378496 Opioid analgesics and 3-hydroxyacetanilide for treating pain
12/25/2014US20140378495 Rifaximin derivative and uses thereof
12/25/2014US20140378493 Fused Bicyclic Oxazolidinone CETP Inhibitor
12/25/2014US20140378491 Cycloalkyl-substituted pyrimidinedione compounds
12/25/2014US20140378490 Formulations of Phenyl Uracil Compounds
12/25/2014US20140378489 Methods of preventing and treating diabetes by inhibiting serotonin synthesis
12/25/2014US20140378485 Quinazolinone derivatives as hcv inhibitors
12/25/2014US20140378482 Compositions and methods for potentiating immune response for the treatment of infectious diseases and cancer
12/25/2014US20140378481 Inhibitors of the fibroblast growth factor receptor
12/25/2014US20140378480 Antiviral compound and cox-2 inhibitor combination therapy for functional somatic syndromes, including combination of famciclovir and celecoxib
12/25/2014US20140378479 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
12/25/2014US20140378478 Small Molecule Xanthine Oxidase Inhibitors and Methods of Use
12/25/2014US20140378477 Mct protein inhibitor-related prognostic and therapeutic methods
12/25/2014US20140378476 Method for treating pain syndrome and other disorders
12/25/2014US20140378474 5-membered heteroarylcarboxamide derivatives as plasma kallikrein inhibitors
12/25/2014US20140378472 Amorphous vilazodone hydrochloride, a process for its preparation and pharmaceutical compositions thereof
12/25/2014US20140378470 Methods of treating cancer
12/25/2014US20140378467 Role of N-2-Hydroxy-Ethyl-Piperazine-N'-2-Ethane Sulfonic Acid (HEPES) in Pain Control and Reversal of Demyelinization Injury
12/25/2014US20140378466 Derivatives of n-(arylamino) sulfonamides as inhibitors of mek
12/25/2014US20140378465 Method of treating diabetes
12/25/2014US20140378464 Pyrimidinedione compounds
12/25/2014US20140378463 IP receptor agonist heterocyclic compounds
12/25/2014US20140378456 Benzimidazole Derivatives As PI3 Kinase Inhibitors
12/25/2014US20140378454 Novel methods
12/25/2014US20140378450 Oxazolidin-2-one compounds and uses thereof
12/25/2014US20140378449 Triazolopyridine jak inhibitor compounds and methods
12/25/2014US20140378445 Methods for treating vascular leak syndrome
12/25/2014US20140378443 Novel Compositions and Methods of Treating HIV-1 Infections Using Same
12/25/2014US20140378442 Phthalazinone derivatives
12/25/2014US20140378441 Therapeutic agent for ocular fundus disease
12/25/2014US20140378440 Baclofen and acamprosate based therapy of neurological disorders
12/25/2014US20140378435 Inhibition of Filovirus Entry Into Cells and Uses Thereof
12/25/2014US20140378431 Triazolo[4,5-d]pyrimidine derivatives
12/25/2014US20140378427 Cabazitaxel-platinum nanoparticles and methods of using same
12/25/2014US20140378426 Methods and compositions for enhancing visual function
12/25/2014US20140378425 Biomarkers for diagnosis of lung diseases and methods of use thereof
12/25/2014US20140378424 Estrogen receptor modulators for reducing body weight
12/25/2014US20140378423 1-phenyl-2-pyridinyl alkyl alcohol compounds as phosphodiesterase inhibitors
12/25/2014US20140378422 Combination of a RTK inhibitor with an anti-estrogen and use thereof for the treatment of cancer
12/25/2014US20140378421 NEW CYCLOHEXYLAMINE DERIVATIVES HAVING beta2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES
12/25/2014US20140378420 Methods for the treatment of breast cancer
12/25/2014US20140378416 Silyl-containing heterocyclic compounds and methods of use thereof for the treatment of viral diseases
12/25/2014US20140378414 Cyclodextrin-based polymers for therapeutic delivery
12/25/2014US20140378412 Methods of making and using a ruminant gas reduction composition
12/25/2014US20140378411 Hyaluronic acid and its use for treating venous insufficiency and varicose veins
12/25/2014US20140378410 Composition for inhibiting after-cataract and method for preparing same
12/25/2014US20140378409 Effect potentiator for antitumor agents
12/25/2014US20140378407 Process for preparing stable pharmaceutical compositions of compounds susceptible to hydrolysis
12/25/2014US20140378406 Silver based gels for antimicrobial applications
12/25/2014US20140378405 Salix extract, its use and formulations containing it
12/25/2014US20140378404 Treatment of Patients Suffering from Cancer
12/25/2014US20140378403 Compounds For Reducing Drug Resistance And Uses Thereof
12/25/2014US20140378401 Ophthalmic Lipophilic and Hydrophilic Drug Delivery Vehicle Formulations
12/25/2014US20140378398 Pharmaceutical combinations for the treatment of metabolic disorders
12/25/2014US20140378397 Carnitine Retention
12/25/2014US20140378385 Histone Deacetylase 6 Selective Inhibitors for the Treatment of Bone Disease
12/25/2014US20140378379 Combination therapy
12/25/2014US20140377838 Stabilization of biomolecules using sugar polymers
12/25/2014US20140377382 Cannabinoid-containing plant extracts as neuroprotective agents
12/25/2014US20140377380 Methods and compositions for treating nephrogenic diabetes insipidus
12/25/2014US20140377378 Methods of distributing a pharmaceutical product comprising nitric oxide gas for inhalation
12/25/2014US20140377376 Dialysis precursor composition
12/25/2014US20140377375 Skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
12/25/2014US20140377374 Materials and methods for treating diarrhea
12/25/2014US20140377368 Chitosan beads and filler comprising such beads
12/25/2014US20140377365 Sustained-release formulation of rotigotine
1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 7860